— Stryker (NYSE: SYK) reported fourth quarter 2019 earnings of $2.49 per share, vs. $2.46 per share expected. — Total sales grew 8.8% to $4.13 billion vs. expected $4.11 billion. Organic sale grew 8% in Q4. Orthopaedics sales increased 6.7% year-over-year to $1.5 billion. — Adjusted EPS is estimated to be in the range of […]
“— Stryker (NYSE: SYK) reported fourth quarter 2019 earnings of $2.49 per share, vs. $2.46 per share expected. — Total sales grew 8.8% to $4.13 billion vs. expected $4.11 billion. Organic sale grew 8% in Q4. Orthopaedics sales increased 6.7% year-over-year to $1.5 billion. — Adjusted EPS is estimated to be in the range of […]
· January 28, 2020
— Stryker (NYSE: SYK) reported fourth quarter 2019 earnings of $2.49 per share, vs. $2.46 per share expected.
— Total sales grew 8.8% to $4.13 billion vs. expected $4.11 billion. Organic sale grew 8% in Q4. Orthopaedics sales increased 6.7% year-over-year to $1.5 billion.
— Adjusted EPS is estimated to be in the range of $9.00 to $9.20 for 2020 and in the range of $2.05 and $2.10 for 1Q20.
— 2020 organic net sales growth expected to be 6.5% to 7.5%.
— SYK shares traded flat in the after-hours trading session.
